187 related articles for article (PubMed ID: 24218117)
1. Utility of serodiagnostics designed for use in the United States for detection of Lyme borreliosis acquired in Europe and vice versa.
Wormser GP; Tang AT; Schimmoeller NR; Bittker S; Cooper D; Visintainer P; Aguero-Rosenfeld ME; Ogrinc K; Strle F; Stanek G
Med Microbiol Immunol; 2014 Feb; 203(1):65-71. PubMed ID: 24218117
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of serologic tests for lyme disease.
Steere AC; McHugh G; Damle N; Sikand VK
Clin Infect Dis; 2008 Jul; 47(2):188-95. PubMed ID: 18532885
[TBL] [Abstract][Full Text] [Related]
3. Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe.
Branda JA; Strle F; Strle K; Sikand N; Ferraro MJ; Steere AC
Clin Infect Dis; 2013 Aug; 57(3):333-40. PubMed ID: 23592827
[TBL] [Abstract][Full Text] [Related]
4. Improved Serodiagnostic Performance for Lyme Disease by Use of Two Recombinant Proteins in Enzyme-Linked Immunosorbent Assay Compared to Standardized Two-Tier Testing.
Bradshaw GL; Thueson RK; Uriona TJ
J Clin Microbiol; 2017 Oct; 55(10):3046-3056. PubMed ID: 28768731
[TBL] [Abstract][Full Text] [Related]
5. C6 Peptide-Based Multiplex Phosphorescence Analysis (PHOSPHAN) for Serologic Confirmation of Lyme Borreliosis.
Pomelova VG; Korenberg EI; Kuznetsova TI; Bychenkova TA; Bekman NI; Osin NS
PLoS One; 2015; 10(7):e0130048. PubMed ID: 26147441
[TBL] [Abstract][Full Text] [Related]
6. Concordance of four commercial enzyme immunoassay and three immunoblot formats for the detection of Lyme borreliosis antibodies in human serum: the two-tier approach remains.
Dickeson DJ; Chen SC; Sintchenko VG
Pathology; 2016 Apr; 48(3):251-6. PubMed ID: 27020501
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic parameters of modified two-tier testing in European patients with early Lyme disease.
Baarsma ME; Schellekens J; Meijer BC; Brandenburg AH; Souilljee T; Hofhuis A; Hovius JW; van Dam AP
Eur J Clin Microbiol Infect Dis; 2020 Nov; 39(11):2143-2152. PubMed ID: 32632699
[TBL] [Abstract][Full Text] [Related]
8. Immune responses to borrelial VlsE IR6 peptide variants.
Sillanpää H; Lahdenne P; Sarvas H; Arnez M; Steere A; Peltomaa M; Seppälä I
Int J Med Microbiol; 2007 Feb; 297(1):45-52. PubMed ID: 17234451
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of the ZEUS Borrelia VlsE1/pepC10 assay in European LB patients: a case-control study.
Baarsma ME; Vrijlandt A; Ursinus J; Zaaijer HL; Jurriaans S; van Dam AP; Hovius JW
Eur J Clin Microbiol Infect Dis; 2022 Mar; 41(3):387-393. PubMed ID: 34806121
[TBL] [Abstract][Full Text] [Related]
10. C6 peptide enzyme immunoassay in Lyme borreliosis serology.
Rouhiainen M; Pietikäinen A; Kortela E; Kanerva MJ; Oksi J; Hytönen J
J Microbiol Methods; 2021 Jan; 180():106122. PubMed ID: 33326821
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of lyme borreliosis.
Aguero-Rosenfeld ME; Wang G; Schwartz I; Wormser GP
Clin Microbiol Rev; 2005 Jul; 18(3):484-509. PubMed ID: 16020686
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis].
Zajkowska JM; Kondrusik M; Pancewicz SA; Grygorczuk S; Jamiołkowski J; Stalewska J
Pol Merkur Lekarski; 2007 Aug; 23(134):95-9. PubMed ID: 18044336
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of bioMérieux's Dissociated Vidas Lyme IgM II and IgG II as a First-Tier Diagnostic Assay for Lyme Disease.
Molins CR; Delorey MJ; Replogle A; Sexton C; Schriefer ME
J Clin Microbiol; 2017 Jun; 55(6):1698-1706. PubMed ID: 28330884
[TBL] [Abstract][Full Text] [Related]
14. Editorial commentary: laboratory testing for Lyme disease: time for a change?
Weinstein A
Clin Infect Dis; 2008 Jul; 47(2):196-7. PubMed ID: 18532894
[No Abstract] [Full Text] [Related]
15. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.
Weiner ZP; Crew RM; Brandt KS; Ullmann AJ; Schriefer ME; Molins CR; Gilmore RD
Clin Vaccine Immunol; 2015 Nov; 22(11):1176-86. PubMed ID: 26376927
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a Novel Microarray Immunoblot Assay for Detection of IgM- and IgG-Class Antibodies to Borrelia burgdorferi.
Theel ES; Sorenson M; Granger D
J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30135227
[TBL] [Abstract][Full Text] [Related]
18. Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.
Branda JA; Linskey K; Kim YA; Steere AC; Ferraro MJ
Clin Infect Dis; 2011 Sep; 53(6):541-7. PubMed ID: 21865190
[TBL] [Abstract][Full Text] [Related]
19. Effect of Borrelia burgdorferi genotype on the sensitivity of C6 and 2-tier testing in North American patients with culture-confirmed Lyme disease.
Wormser GP; Liveris D; Hanincová K; Brisson D; Ludin S; Stracuzzi VJ; Embers ME; Philipp MT; Levin A; Aguero-Rosenfeld M; Schwartz I
Clin Infect Dis; 2008 Oct; 47(7):910-4. PubMed ID: 18724824
[TBL] [Abstract][Full Text] [Related]
20. Modified interpretation criteria significantly improve performance of commercially available confirmatory assays for the serodiagnosis of Lyme borreliosis: a case-control study with clinically defined serum samples.
Hauser U
Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):529-539. PubMed ID: 30715667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
